Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration.
D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000096:biosynthesis* / Q000737:chemistry* / Q000235:genetics / Q000302:isolation & purification; D019281:Dimerization; D004789:Enzyme Activation; D004795:Enzyme Stability; D004926:Escherichia coli / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D002479:Inclusion Bodies / Q000235:genetics / Q000378:metabolism*; D010084:Oxidation-Reduction; D017510:Protein Folding; D020673:Protein Renaturation; D011522:Protons; D011786:Quality Control; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000737:chemistry / Q000302:isolation & purification; D013654:Taurine / Q000031:analogs & derivatives* / Q000737:chemistry*; D013696:Temperature; D016212:Transforming Growth Factor beta
C525718:BMP2 protein, human; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D011522:Protons; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta; C499469:recombinant human bone morphogenetic protein-2; C050927:2-(N-cyclohexylamino)ethanesulfonic acid; D013654:Taurine